Kalvista Pharmaceuticals IncEigentümerstruktur
| Preis (2026-06-12) | 52W Hoch | 52W Tief |
| 27 USD | 27 USD | 10,41 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 27 USD | 7 | 3 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 53.240.888 | 14,37 | 0,94 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Kalvista Pharmaceuticals Inc
Mitarbeiter 275
Handelsplatz NASDAQ
Ticker Symbol KALV
IPO Datum 2015-04-09
Adresse 200 Crossing Boulevard, Framingham, MA, United States, 01702
Webseite https://www.kalvista.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Benjamin L. Palleiko | CEO & Director |
| 2 | Mr. Brian Piekos | Chief Financial Officer |
| 3 | Mr. Bilal Arif | Chief Operating Officer |
| 4 | Dr. Paul K. Audhya M.B.A., M.D. | Chief Medical Officer |
| 5 | Mr. Ryan Baker | Head of Investor Relations |
| 6 | Mr. Brian Krex J.D. | General Counsel |
| 7 | Dr. Christopher L. Hamblett Ph.D. | Senior Vice President of Corporate Development |
| 8 | Ms. Linea Aspesi | Chief People Officer |
| 9 | Ms. Rachel M. Morten | Senior Vice President of Regulatory Affairs & QA |
| 10 | Dr. Christopher M. Yea Ph.D. | Chief Development Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | VR Adviser, LLC | 0,00% | 0,00 Mio. USD |
| 2 | Frazier Life Sciences Management, L.P. | 0,00% | 0,00 Mio. USD |
| 3 | Suvretta Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 4 | TANG CAPITAL MANAGEMENT LLC | 0,00% | 0,00 Mio. USD |
| 5 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 6 | SILVERARC CAPITAL MANAGEMENT, LLC | 0,00% | 0,00 Mio. USD |
| 7 | Capital World Investors | 0,00% | 0,00 Mio. USD |
| 8 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 9 | Point72 Asset Management, L.P. | 0,00% | 0,00 Mio. USD |
| 10 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 11 | Millennium Management LLC | 0,00% | 0,00 Mio. USD |
| 12 | Vestal Point Capital LP | 0,00% | 0,00 Mio. USD |
| 13 | Parkman Healthcare Partners LLC | 0,00% | 0,00 Mio. USD |
| 14 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 15 | Kynam Capital Management, LP | 0,00% | 0,00 Mio. USD |
| 16 | Woodline Partners LP | 0,00% | 0,00 Mio. USD |
| 17 | Octagon Capital Advisors LP | 0,00% | 0,00 Mio. USD |
| 18 | Squadron Capital Management LLC | 0,00% | 0,00 Mio. USD |
| 19 | Emerald Advisers, LLC | 0,00% | 0,00 Mio. USD |
| 20 | Armistice Capital, LLC | 0,00% | 0,00 Mio. USD |